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OBJECTIVES We sought to assess the natural history of a cohort of asymptomatic individuals with very high
(1,000) calcium scores (CSs) on a screening electron beam tomography (EBT) not
submitted to further testing after the initial scan. We also compared the outcome of our
prospective cohort with that of historical controls with severe abnormalities on myocardial
perfusion imaging (MPI).
BACKGROUND Coronary calcium detected on EBT imaging has been shown to correlate with the total plaque
burden. However, there is still controversy as to the prognostic significance of calcium, as
some investigators believe that the presence of coronary calcification may stabilize the
atherosclerotic plaque.
METHODS Ninety-eight asymptomatic subjects (mean age: 62  10) were followed for an average of
17  11 months (range: 4 to 36 months) after undergoing EBT screening for the occurrence
of hard coronary events (HCEs), defined as myocardial infarction or coronary death. All
patients had an initial CS 1,000, and in none did the results of the EBT screening lead to
further invasive or non-invasive testing.
RESULTS During the follow-up period, 35 patients (36%) suffered an HCE. All events were recorded
in the first 28 months of follow-up. Subjects with HCEs had higher initial CSs than subjects
not suffering HCEs (1,561  270 vs. 1,199  200, p  0.001). The annualized event rate
in subjects with a CS 1,000 was significantly greater than that of historical controls with
severe perfusion abnormalities on MPI (25% vs. 7.4%, respectively; p  0.0001).
CONCLUSIONS A high CS (1,000) on a screening EBT in an asymptomatic person portends a very high risk
of an HCE in the short term. This risk appears to be greater than the risk associated with a
severe perfusion abnormality on MPI. (J Am Coll Cardiol 2002;39:225–30) © 2002 by the
American College of Cardiology
Histopathologic studies have demonstrated the correlation
of coronary artery calcification with the presence of athero-
sclerosis (1,2), and there appears to be a modest relationship
between the extent of coronary artery calcification and
severity of luminal stenosis (3–5). Angiography (6,7) and
intravascular ultrasound (8,9) have demonstrated this rela-
tionship, and in spite of the lack of a site-by-site correspon-
dence of calcification and luminal stenosis (10), a high
calcium score (CS) predicts the presence of obstructive
luminal disease, as demonstrated by single photon emission
computed tomography (SPECT) imaging (11), with good
reliability. Nonetheless, neither the severity nor the site of a
vessel obstruction detected at angiography can be used to
predict the occurrence of myocardial infarction (MI) or
cardiac death (hard coronary events [HCEs]) (12,13). On
the contrary, plaque burden appears to be a better determi-
nant of future coronary events (14–16). Nuclear myocardial
perfusion imaging and stress echocardiography are invalu-
able in detecting the presence of obstructive coronary
stenosis. However, though very helpful to assess abnormal
myocardial perfusion and its attendant prognosis, these
imaging modalities cannot be used to estimate the total
plaque burden. On the contrary, electron beam tomography
(EBT) is an anatomic test employed to visualize the
presence of plaque noninvasively.
Much controversy still surrounds the role of coronary
calcification for the prediction of coronary events. Several
published reports support the view that selected asymptom-
atic and symptomatic individuals with coronary calcium on
a screening EBT scan are at high risk for development of
clinical events (17–21). Prior American College of Cardi-
ology/American Heart Association guidelines affirm the
strong negative predictive value of a normal EBT, although
they are less supportive of the positive predictive value of
coronary calcification (22).
In this observational prospective study, we sought to
determine the incidence of HCEs, defined as MI or death,
in a cohort of asymptomatic individuals with high CSs
(1,000) who did not undergo initial stress testing or
coronary angiography driven by the results of the EBT
screening procedure. To gauge the prognostic significance
of these high CSs, indicative of an extensive plaque burden,
we compared the event rate recorded in our cohort with that
reported in the literature for symptomatic patients with
severe abnormalities on myocardial functional studies.
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METHODS
Patient population. Data gathering started after study
approval by the Medical Investigation Committee in our
institution. All records for asymptomatic subjects submitted
to EBT scanning during the period of June 1, 1996, to
March 30, 1999, were reviewed. To be entered in the
database, individuals had to be asymptomatic for cardiovas-
cular disease and have no prior history of coronary artery
disease (CAD). Furthermore, all patients had to have an
initial CS 1,000 (Agatston method) (23). Individuals
whose EBT results triggered further cardiovascular testing,
including functional testing or angiography, were excluded
from the final analysis.
A total of 104 asymptomatic subjects with a CS 1,000
were identified. We could not obtain follow-up information
on two subjects, and four patients underwent interventions
triggered by their EBT results and were excluded from the
analysis. Therefore, our final sample included 98 patients.
Data collection. Information regarding the patients’ de-
mographics, past medical history and clinical data were
obtained through questionnaires distributed at the time of
the initial EBT screening and—where available—medical
record review. The accuracy of the medical records was
confirmed at the time of patients’ first interview. The
information we collected regarded only the presence of
categorical risk factors, and most risk factors were self-
reported by the individuals undergoing EBT testing. No
continuous variables were obtained. Systemic arterial hyper-
tension was defined as current use of anti-hypertensive
medications or known but untreated hypertension. Current
smoking or cessation of smoking within three months of
testing was defined as positive smoking status. Hypercho-
lesterolemia was defined as currently receiving cholesterol-
lowering medications or the presence of known but un-
treated hypercholesterolemia. Patients receiving insulin or
oral hypoglycemic agents were classified as diabetic.
Telephone surveys were conducted at 3, 6, 9, 12, 18, 24
and 36 months from enrollment to collect information
regarding the occurrence of HCEs (MI and death). All
events were verified by means of medical chart and death
certificate review. If a patient suffered more than one HCE
during the follow-up period (two consecutive MIs or MI
followed by death), only the first event was counted. The
time from EBT screening to first event was recorded in
months, and patient-months were used as an estimate of
event-free survival (patients-months were calculated as the
sum of all event-free months/number of events). Enroll-
ment ceased six months before the last telephone contact.
Imaging. Electron beam tomography imaging was per-
formed using an Imatron C-100 scanner (Imatron, South
San Francisco, California), with a 3-mm slice thickness and
100-ms imaging time. Tomographic imaging was triggered
at 80% of the R-to-R interval on the 12-lead electrocardio-
gram during two end-inspiratory breath-holding periods.
This was done to ensure minimal motion artifact and image
distortion.
Scoring of all calcified areas was performed using the
standard methodology described by Agatston et al. (23). A
single investigator (A.Z.) blinded to the clinical data re-
viewed all EBT studies and confirmed the CSs. We did not
consider it necessary to measure intra-reader scoring vari-
ability, because the latter is negligible with CSs in the range
we selected (24).
Statistical analysis. Categorical variables were compared
using the Fischer exact test, and continuous variables were
compared using the Student t test. Demographic data were
compared using the likelihood ratio derived from chi-
square. Curves describing the probability of event-free
survival were obtained by plotting the number of patients
free of events at each follow-up point. A patient who
suffered an event at any point continued to be counted in the
event group at the next follow-up. All calculations of
significance were two-tailed, and a p  0.05 was deemed
necessary to achieve significance.
A MEDLINE search was conducted to identify recent
publications that reported on hard outcome of patients
found to have severe abnormalities on myocardial perfusion
imaging (MPI) or stress echocardiography. Because such
abnormalities probably point to the presence of multifocal
obstructive disease, we considered these historical controls
as plausible matches for our patients with extensive coronary
artery calcification.
RESULTS
The clinical characteristics of the subjects submitted to EBT
screening are shown in Table 1. The majority of our patients
were self-referred, and only a small number were referred by
primary care physicians. Of the original 104 patients
screened, two patients could not be reached for follow-up
and were excluded. Four patients underwent cardiac cathe-
Abbreviations and Acronyms
CS  calcium score
CAD  coronary artery disease
EBT  electron beam tomography
HCE  hard cardiac event
MI  myocardial infarction
MPI  myocardial perfusion imaging
SPECT  single photon emission computed tomography
Table 1. Clinical Characteristics of Study Patients
Men, no. (%) 98 (71)
Average age at entry (yrs) 62  10
Average months of follow-up (range) 17  11 (4–36)
Hypertension, no. (%) 39 (40)
Diabetes Mellitus, no. (%) 17 (17)
Current Smokers, no. (%) 26 (27)
Hypercholesterolemia, no. (%) 55 (56)
Average CS 1,328  287
CS  calcium score; no.  number.
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terization after the EBT study. Two of these patients
underwent percutaneous coronary angioplasty with stent
placement, and one underwent coronary bypass surgery,
while the fourth patient was treated medically. These four
patients were also excluded from analysis. The remaining
98 patients were followed for an average of 17 11 months
(range: 4 to 36 months). The average CS for the entire
cohort was 1,328  287 (range: 1,000 to 2,010).
In total, we recorded 35 HCEs during the follow-up
period. The mean age of patients with and without events
during follow-up was not statistically different (61 9 years
and 63  8 years, respectively, p  NS). However, the CSs
of patients who sustained an HCE during the follow-up
period was significantly greater than that of patients who
did not (1,561  270 vs. 1,199  200, p  0.001).
Treatment with HmG-CoA reductase inhibitors was em-
ployed at any time before or after the screening EBT scan in
27% of the patients without an HCE and 26% of the
patients with an HCE (p  NS). The same was true of
therapy with beta-adrenergic blocking agents (24% vs. 20%,
p  NS).
Cardiac mortality comprised 12 events: seven deaths were
not preceded by a documented MI and happened an average
of 19  7 months from the screening EBT. The remaining
five deaths were preceded by an MI suffered after an average
time of 15  6 months from the screening EBT. Death in
these five cases occurred within zero to nine months from
MI. Of the 12 patients who died, two patients had devel-
oped angina after a follow-up of six and eight months from
EBT screening and underwent percutaneous coronary artery
angioplasty at that time. Both of these patients died within
five months of the procedure.
Morbid events included 23 nonfatal MIs recorded at an
average of 18  7 months from the screening EBT. There
was no statistical difference in age and CS between the
patients who suffered a fatal cardiac event and those who
suffered a nonfatal MI (mean age: 61  10 years for both
groups and CS  1,555  214 vs. 1,563  270, respec-
tively; p  NS).
The annual absolute event rate for the entire cohort was
25%. In the study group as a whole, there was one event per
30.7 patient-months. For patients with a CS 1,500, the
event rate was 1 per 24.5 patient-months. The difference in
time-course between these two patient groups was statisti-
cally significant (p  0.05). If only the patients who died
were considered, the time to event was further reduced to
18.4 patient-months, and this too was statistically signifi-
cant (p  0.02) compared with the entire cohort.
Although the longest follow-up was 36 months, all
HCEs occurred within 28 months from the time of EBT
screening. Eleven patients were followed for longer than 28
months and up to 36 months but suffered no events. A curve
describing the probability of event-free survival at each
individual follow-up time is presented in Figure 1.
Comparison with historical controls. Our cohort showed
a greater mortality and morbidity than historical controls
submitted to functional stress imaging. Hachamovitch et al.
(25) published data on the outcome of 2,200 consecutive
patients with no prior history of CAD submitted to dual
isotope SPECT imaging. All patients had symptoms, either
atypical (70%) or typical (30%). During a mean follow-up of
566  142 days, the HCE rate for patients with severely
abnormal scan results was 10% (approximately 7% per year).
The same group reported on the outcome of 5,183 patients
followed for an average of 1.8 years after having been
submitted to MPI (26). Of 5,183 patients, 64% had
experienced either typical or atypical angina before testing,
and 21% had suffered an MI. The yearly HCE rate was
7.1% in the patients with severely abnormal scan results and
12.3% for all patients with moderately and severely abnor-
mal test results considered together. An extensive review of
outcome studies performed in a variety of patients submit-
ted to MPI showed an average annual HCE rate of 7.4% in
individuals with abnormal scans and a rate of 0.6% in
subjects with normal scans (27).
Elhendy et al. (28) studied a group of 563 high-risk
diabetic patients by means of exercise echocardiography.
Again, over two thirds of the patients studied had anginal
Figure 1. Probability of survival free of events in 98 consecutive asymptomatic subjects with a calcium score 1,000 on a screening electron beam
tomography scan.
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symptoms or had suffered a prior MI. Patients with induc-
ible wall motion abnormalities in multiple territories
showed an HCE rate of 32.8% at five years (approximately
7% annualized event rate).
In every comparison, our asymptomatic subjects with CSs
1,000 demonstrated a statistically greater event rate (p 
0.0001) than patients with severely abnormal stress test
results.
DISCUSSION
This study shows that the presence of a high coronary artery
CS on EBT imaging in asymptomatic patients portends a
very high risk for HCE. Previous EBT outcome studies
included very few cases with a CS 1,000, and this is the
first large series of asymptomatic patients with such score
values. Although medical treatment of these individuals may
have been intensified by the detection of extensive coronary
calcification, the screening test was not immediately fol-
lowed by any coronary intervention or further risk stratifi-
cation by means of functional studies. Stress testing or
coronary interventions were performed during the follow-up
procedure only as warranted by clinical circumstances such
as the appearance of angina. Therefore, this analysis repre-
sents a true natural history of extensive asymptomatic CAD.
Prior evidence of prognostic role of calcification.
Margolis et al. (29) reported that symptomatic patients with
coronary calcification seen during angiography had a five-
year survival rate of 58% compared with 87% for patients
without calcification. They further noted that the prognostic
significance of coronary artery calcification appeared to be
independent of information obtained during angiography.
The presence of calcification of the coronary arteries on
fluoroscopy was an independent predictor of death and MI
in a study by Detrano et al. (30). These authors reported on
the outcome of 1,461 asymptomatic individuals followed for
55 months after having undergone fluoroscopy screening to
identify coronary artery calcification. During the follow-up
period, there were 35 coronary deaths and 43 nonfatal MIs.
Subjects with calcification in more than one vessel were 2.2
times more likely to suffer an event than subjects with one or
no calcified vessels. Furthermore, the number of calcified
vessels was an independent predictor of events. Given the
much lower sensitivity of fluoroscopy compared with EBT,
it is plausible that the calcifications seen on fluoroscopy by
Margolis et al. (29) and Detrano et al. (30) were rather
extensive.
The value of EBT screening for coronary calcium and as
a predictor of cardiovascular events is still being disputed
(22) and is undergoing intense investigation. In 1,172
self-referred asymptomatic individuals, the presence of a CS
160 was associated with an odds ratio of 22 for either
developing an HCE or requiring a coronary revasculariza-
tion procedure after an average of 3.6 years from EBT
screening (19). A recent trial showed that a CS 75th
percentile in asymptomatic physician-referred individuals is
highly predictive of the occurrence of HCEs in the short
term (17). Because a CS 1,000 places an individual in at
least the 75th percentile, and perhaps even above the 90th
percentile for most adults of both genders (31), our analysis
falls in line with other studies that proved these relative
score thresholds to be indicative of substantially elevated
cardiovascular risk (17).
Mechanisms explaining vascular fragility. Several expla-
nations could be offered for the occurrence of the extremely
elevated event rate we observed. The most plausible is that
extensive calcification of the coronary arteries indicates
disseminated atherosclerosis. The calcified areas should not
necessarily be considered the areas at immediate risk of
sudden rupture or erosion but rather markers for the
presence of unstable atherosclerotic plaques admixed be-
tween the more heavily calcified areas (1). A recent report by
Huang et al. (32) supports the hypothesis that calcified
plaques are less prone to rupture. These investigators con-
ducted an in vitro study of the elastic properties of 10 stable
plaques and 10 plaques that had undergone rupture before
the patient’s death. The authors concluded that calcified
atherosclerotic plaques were more stable and less prone to
rupture than plaques with a large lipid pool. These results,
however, are in contrast with other experimental data
produced with in vitro simulations by Veress et al. (33), who
suggested that atherosclerotic plaques show an increased
tendency to rupture when a calcium layer is added to a stable
plaque. Furthermore, Demer (34) demonstrated an extreme
fragility of calcified rabbit coronary arteries exposed in vitro
to stretching with angioplasty balloons, while Fitzgerald et
al. (35) observed a greater propensity to dissection during in
vivo angioplasty of calcified human coronary arteries than
noncalcified arteries (35). Finally, Mascola et al. (36) re-
ported that the culprit coronary artery responsible for an
acute event is most often calcified. In the latter analysis, the
investigators concluded that the weight of the evidence
favors the concept that coronary calcification is an important
risk factor for the development of HCEs. Nonetheless,
although the culprit artery is more often calcified, the
specific region of plaque rupture or erosion might not be.
Significance of plaque burden. Although the issue of the
relationship between arterial fragility and focal calcification
remains controversial, it is clear that the total atherosclerotic
plaque burden is a more determinative factor in the occur-
rence of HCEs than the presence of focal luminal stenoses
(14,37). Goldstein et al. (14) showed that the presence of
multiple complex plaques predicted the recurrence of acute
coronary events that did not necessarily occur at the site of
the most severe obstruction. This happened in spite of a
more frequent use of coronary revascularization procedures
in patients with multiple complex plaques.
The presence of multiple perfusion abnormalities on a
myocardial perfusion study in patients with anginal symp-
toms indicates the development of obstructive luminal
disease, which may well be caused by stable plaques not
prone to rupture. Thus, functional abnormalities, although
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very prognostically important (38), may not necessarily carry
as severe a prognosis as extensive atherosclerotic disease. On
the other hand, the actual risk of an HCE in patients with
severely abnormal functional tests could be greater than
reported in the literature. In fact, it is likely that the majority
of individuals with very abnormal test results would undergo
coronary angiography and revascularization early after test
completion. This might limit the occurrence of events,
although large-scale randomized trials have shown that
improved event-free survival can be achieved only in specific
subsets of symptomatic patients submitted to elective revas-
cularization procedures (39–41).
Study limitations. Our study was subject to a few limita-
tions. The size of our patient cohort was small, although
this is the largest published series of asymptomatic individ-
uals with a CS1,000 to date. Today it would be extremely
rare to find individuals with a CS 1,000 not submitted to
further testing, because the interest and attention of clini-
cians to the prognostic significance of coronary calcification
has exponentially increased since the time of our study
inception. The majority of patients we followed were
self-referred. This might represent a more health conscious
group of individuals or a group of subjects that, despite the
declared absence of chest discomfort, actually suffered atyp-
ical symptoms and wondered about their nature. This
preselection bias could be overcome only by conducting a
population-based study where no intervention after the
EBT screening is allowed. This approach is becoming less
practical and ethical as more outcome studies supporting the
negative impact of coronary calcification are published. The
design of our study did not include the measurement of
markers of inflammation such as high sensitivity C-reactive
protein, an important marker of risk of future coronary
events (42–44). It is conceivable that the individuals who
suffered an event in our study might have had the highest
C-reactive protein levels, therefore representing a more
unstable group. Interestingly, all events happened in the first
28 months of follow-up, with no event registered after that
period. In theory, it is plausible that the unstable patients
suffered an event earlier, while in the remaining patients
calcification of the coronary arteries indicated the presence
of a more stable form of disease.
Conclusions. The prognostic significance of coronary cal-
cification is undergoing intense investigation, and it is
slowly becoming accepted as an additional significant risk
factor for coronary heart disease. Our study shows that the
presence of high CSs (1,000) on a screening EBT in
asymptomatic persons portends a very high risk of HCEs.
The risk seems to be greater than severe abnormalities seen
on functional myocardial studies conducted in symptomatic
patients. These data may need to be taken into consider-
ation when designing randomized trials of asymptomatic
individuals expected to undergo EBT screening. Patients
with such high scores deserve aggressive medical manage-
ment and further risk stratification with serologic testing for
markers of inflammation, and they are likely to require
functional stress testing to demonstrate the presence of
inducible myocardial ischemia.
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